Ferro CJ - Search Results

1

Coronary microvascular dysfunction: a key step in the development of uraemic cardiomyopathy?

Radhakrishnan A, Pickup LC, Price AM, Law JP, Edwards NC, Steeds RP, Ferro CJ, Townend JN. Radhakrishnan A, et al. Among authors: ferro cj. Heart. 2019 Sep;105(17):1302-1309. doi: 10.1136/heartjnl-2019-315138. Epub 2019 Jun 25. Heart. 2019. PMID: 31239278 Free PMC article. Review.

2

The treatment of coronary artery disease in patients with chronic kidney disease.

Edwards NC, Steeds RP, Ferro CJ, Townend JN. Edwards NC, et al. Among authors: ferro cj. QJM. 2006 Nov;99(11):723-36. doi: 10.1093/qjmed/hcl101. Epub 2006 Oct 13. QJM. 2006. PMID: 17040978 Review.

3

Myocardial disease in systemic vasculitis and autoimmune disease detected by cardiovascular magnetic resonance.

Edwards NC, Ferro CJ, Townend JN, Steeds RP. Edwards NC, et al. Among authors: ferro cj. Rheumatology (Oxford). 2007 Jul;46(7):1208-9. doi: 10.1093/rheumatology/kem077. Epub 2007 May 3. Rheumatology (Oxford). 2007. PMID: 17478468 No abstract available.

4

Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fraction.

Edwards NC, Ferro CJ, Townend JN, Steeds RP. Edwards NC, et al. Among authors: ferro cj. Heart. 2008 Aug;94(8):1038-43. doi: 10.1136/hrt.2007.137539. Epub 2008 Feb 28. Heart. 2008. PMID: 18308865

5

Subclinical abnormalities of left ventricular myocardial deformation in early-stage chronic kidney disease: the precursor of uremic cardiomyopathy?

Edwards NC, Hirth A, Ferro CJ, Townend JN, Steeds RP. Edwards NC, et al. Among authors: ferro cj. J Am Soc Echocardiogr. 2008 Dec;21(12):1293-8. doi: 10.1016/j.echo.2008.09.013. J Am Soc Echocardiogr. 2008. PMID: 19041571

6

Is lowering phosphate exposure the key to preventing arterial stiffening with age?

Ferro CJ, Chue CD, Steeds RP, Townend JN. Ferro CJ, et al. Heart. 2009 Nov;95(21):1770-2. doi: 10.1136/hrt.2008.162594. Epub 2009 Mar 24. Heart. 2009. PMID: 19321494

7

Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial.

Edwards NC, Steeds RP, Stewart PM, Ferro CJ, Townend JN. Edwards NC, et al. Among authors: ferro cj. J Am Coll Cardiol. 2009 Aug 4;54(6):505-12. doi: 10.1016/j.jacc.2009.03.066. J Am Coll Cardiol. 2009. PMID: 19643310 Free article. Clinical Trial.

8

Arterial stiffness in chronic kidney disease: causes and consequences.

Chue CD, Townend JN, Steeds RP, Ferro CJ. Chue CD, et al. Among authors: ferro cj. Heart. 2010 Jun;96(11):817-23. doi: 10.1136/hrt.2009.184879. Epub 2010 Apr 20. Heart. 2010. PMID: 20406771 Review.

9

Reduction of blood pressure already in the normal range further regresses left ventricular mass.

Chue CD, Edwards NC, Ferro CJ, Steeds RP, Townend JN. Chue CD, et al. Among authors: ferro cj. Heart. 2010 Jul;96(13):1080; author reply 1080. doi: 10.1136/hrt.2009.191619. Epub 2010 May 18. Heart. 2010. PMID: 20483900 No abstract available.

10

The effect of spironolactone upon corticosteroid hormone metabolism in patients with early stage chronic kidney disease.

Hammer F, Edwards NC, Hughes BA, Steeds RP, Ferro CJ, Townend JN, Stewart PM. Hammer F, et al. Among authors: ferro cj. Clin Endocrinol (Oxf). 2010 Nov;73(5):566-72. doi: 10.1111/j.1365-2265.2010.03832.x. Clin Endocrinol (Oxf). 2010. PMID: 20550533 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters